474 Genomic landscape of metastatic colorectal cancer.
http://www.nature.com/ncomms/2014/141114/ncomms6457/full/ncomms6457.html
473 A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.
http://www.nature.com/nm/journal/v20/n11/abs/nm.3646.html
472 Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
http://www.nature.com/nature/journal/v515/n7525/full/nature13638.html
471 Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
http://www.nature.com/nature/journal/v515/n7525/full/nature13862.html
470 Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.
http://stm.sciencemag.org/content/6/261/261ra151
469 Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.
http://www.nature.com/srep/2014/141031/srep06855/full/srep06855.html
468 Cyclin C is a haploinsufficient tumour suppressor.
http://www.nature.com/ncb/journal/v16/n11/abs/ncb3046.html
467 Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe.
http://stm.sciencemag.org/content/6/260/260ra149
466 Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
http://www.pnas.org/content/111/42/15172.abstract
465 TOPK inhibitor kills cancer cells by causing a cytokinesis defect and promotes tumor regression in mouse models.
http://stm.sciencemag.org/content/6/259/259ra145.abstract
464 Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancer-protective protein dermcidin.
http://www.pnas.org/content/111/41/14687.abstract
463 ICAM-1 as a molecular target for triple negative breast cancer.
http://www.pnas.org/content/111/41/14710.abstract
462 Different mutations are present in different regions of any given lung cancer, and their pattern may predict patient relapse.
http://www.sciencemag.org/content/346/6206/256.abstract
461 Different regions of a human lung tumor harbor different mutations, possibly explaining why the disease is so tough to treat.
http://www.sciencemag.org/content/346/6206/251.abstract
460 Inhibition of Cancer Cell Proliferation by PPARγ Is Mediated by a Metabolic Switch that Increases Reactive Oxygen Species Levels.
http://www.cell.com/cell-metabolism/abstract/S1550-4131(14)00369-6
459 Bladder cancers arise from distinct urothelial sub-populations.
http://www.nature.com/ncb/journal/v16/n10/abs/ncb3038.html
458 Endothelial podosome rosettes regulate vascular branching in tumour angiogenesis.
http://www.nature.com/ncb/journal/v16/n10/abs/ncb3036.html
457 Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt–β-catenin–mediated intestinal tumor growth and regeneration.
http://stke.sciencemag.org/content/7/345/ra92.abstract
456 The growth of tumours is supported by tumour production of lactic acid, which polarizes tumour-associated macrophages to an M2 phenotype through a pathway dependent on hypoxia-inducible factor 1α.
http://www.nature.com/nature/journal/v513/n7519/full/nature13490.html
455 Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes.
http://www.pnas.org/content/111/38/13948.abstract
|
